Actonel “Drug Holidays” May Carry Increased Hip Fracture Risks: Study
Taking a holiday from bone-strengthening drugs like Actonel and Fosamax may increase the risk of hip fractures, according to the findings of a new study.
Taking a holiday from bone-strengthening drugs like Actonel and Fosamax may increase the risk of hip fractures, according to the findings of a new study.
A new case report warns of a possible link between Reclast bone drug infusions and an increased risk of seizures.
A new study suggests frequent Zometa injections increase the risk of jawbone death for some cancer patients.
A new study reveals that Fosamax and similar osteoporosis drugs failed to provide any benefits in preventing hip fractures after seven years of use.
A new study warns that Fosamax and similar drugs greatly increase the risk of atypical femur fractures after more than five years of use.
A Reclast study's findings indicate the bone drug does no better than a placebo at preventing cartilage loss due to knee osteoarthritis, while still carrying significant risk of side effects.
A new study appears to show the mechanism of action that may cause bone-strengthening drugs like Fosamax to increase the risk of femur fractures.
A new study links continuous use of bisphosphonates, like Fosamax and Boniva, to a vision disorder known as wet age-related macular degeneration.
A new study suggests that bone-strengthing drugs like Fosamax may increase the risk hip fractures among elderly users.
Researchers say preventing falls will do more to prevent hip fractures in the elderly than medication.